Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans

OBJECTIVE: Glucocorticoids (GCs) are regarded as diabetogenic because they impair insulin sensitivity and islet-cell function. This study assessed whether treatment with the glucagon-like peptide receptor agonist (GLP-1 RA) exenatide (EXE) could prevent GC-induced glucose intolerance. RESEARCH DESIG...

Descripción completa

Detalles Bibliográficos
Autores principales: van Raalte, Daniël H., van Genugten, Renate E., Linssen, Margot M.L., Ouwens, D. Margriet, Diamant, Michaela
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024359/
https://www.ncbi.nlm.nih.gov/pubmed/21216851
http://dx.doi.org/10.2337/dc10-1677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024359/
https://www.ncbi.nlm.nih.gov/pubmed/21216851
http://dx.doi.org/10.2337/dc10-1677

Ejemplares similares